Literature DB >> 15775779

Genetic contribution to the acute effects of angiotensin II type 1 receptor blockade.

Wilko Spiering1, Abraham A Kroon, Monique Jmj Fuss-Lejeune, Peter W de Leeuw.   

Abstract

OBJECTIVE: Clinical observations point towards heterogeneity in patients' responses to antihypertensive drugs. As our earlier work showed that angiotensin II (AngII) sensitivity is associated with the A1166C polymorphism of the AngII type 1 receptor (AT1R) gene, we conducted the present study in which the responses to acute AT1R blockade were evaluated.
METHODS: After 7 days of low and high sodium diet, the hormonal as well as systemic and renal hemodynamic responses to acute AT1R blockade with EXP3174 (active metabolite of losartan) were studied in 15 AA and 14 CC essential hypertensive patients. By means of platelet-binding studies the baseline AT1R density (Bmax) and affinity (KD) was tested.
RESULTS: During low and high salt diet, baseline Bmax and KD were comparable between both genotype groups. At baseline, during low salt diet, CC patients had significantly lower glomerular filtration rate and a trend towards lower effective renal plasma flow (ERPF) compared to AA patients. Blood pressure responses to EXP3174 during high salt were significantly blunted in CC patients compared to AA patients (mean arterial pressure: 1.8 versus 7.5%; P < 0.05). During low salt the increase in ERPF (12.9 versus 16.1%; P = 0.08), as well as the decrease in filtration fraction (9.0 versus 14.0%; P = 0.05) and renal vascular resistance (7.5 versus 15.1%; P = 0.06) were blunted in CC patients compared to AA patients. Humoral effects did not differ between the groups.
CONCLUSION: This study shows that the systemic and renal hemodynamic responses to acute AT1R blockade are, at least in part, genetically determined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15775779     DOI: 10.1097/01.hjh.0000163143.66965.06

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

Review 1.  Genetics of arterial hypertension and hypotension.

Authors:  Dieter Rosskopf; Markus Schürks; Christian Rimmbach; Rafael Schäfers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-30       Impact factor: 3.000

Review 2.  Renin-angiotensin-aldosterone system (RAAS) pharmacogenomics: implications in heart failure management.

Authors:  Amber L Beitelshees; Issam Zineh
Journal:  Heart Fail Rev       Date:  2008-03-20       Impact factor: 4.214

3.  The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding.

Authors:  Mickey M Martin; Jessica A Buckenberger; Jinmai Jiang; Geraldine E Malana; Gerard J Nuovo; Maqsood Chotani; David S Feldman; Thomas D Schmittgen; Terry S Elton
Journal:  J Biol Chem       Date:  2007-06-22       Impact factor: 5.157

4.  In silico prediction of ARB resistance: A first step in creating personalized ARB therapy.

Authors:  Shane D Anderson; Asna Tabassum; Jae Kyung Yeon; Garima Sharma; Priscilla Santos; Tik Hang Soong; Yin Win Thu; Isaac Nies; Tomomi Kurita; Andrew Chandler; Abdelaziz Alsamarah; Rhye-Samuel Kanassatega; Yun L Luo; Wesley M Botello-Smith; Bradley T Andresen
Journal:  PLoS Comput Biol       Date:  2020-11-25       Impact factor: 4.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.